The annual Transcatheter Cardiovascular Therapeutics (TCT) conference, held at the Washington Convention Center last month, once again was jam-packed with a huge menu of choices guaranteed to satiate the appetite of any interventional cardiologist, medical device executive or Wall Street analyst.